Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers

AIDS

Volumn 21, Issue 9, 2007, Pages 1091-1101

  Ball, Terry Blake ^a   Ji, Hezhao ^a   Kimani, Joshua ^b   McLaren, Paul ^a   Marlin, Crystal ^a   Hill, Adrian V S ^c   Plummer, Francis Allan ^a,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Public Health Agency of Canada   (Canada)

Author keywords

Gene polymorphism; IL 4 gene cluster; Interferon regulatory factor 1; Resistance to infection by HIV 1

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 4;

ALLELE; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; KAPLAN MEIER METHOD; KENYA; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; WESTERN BLOTTING;

ALLELES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERLEUKIN-4; KENYA; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTITUTION;

EID: 34248531947     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280ef6ae1     Document Type: Article

References (35)

1. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351.
2. Beyrer C, Artenstein AW, Rugpao S, Stephens H, Van Cott TC, Robb ML, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999; 179:59-67.
3. Kulkarni PS, Butera ST, Duerr AC. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Rev 2003; 5:87-103.
4. Louisirirotchanakul S, Liu H, Roongpisuthipong A, Nakayama EE, Takebe Y, Shioda T, et al. Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 64I homozygosity with HIV-1-negative status. J Acquir Immune Defic Syndr 2002; 29:314-315.
5. Liu C, Carrington M, Kaslow RA, Gao X, Rinaldo CR, Jacobson LP, et al. Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2003; 187:1404-1410.
6. Plummer FA, Ball TB, Kimani J, Fowke KR. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett 1999; 66:27-34.
7. Alimonti JB, Koesters SA, Kimani J, Matu L, Wachihi C, Plummer FA, Fowke KR. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J Infect Dis 2005; 191:20-24.
8. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998; 102:1758-1765.
9. Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999; 13:23-29.
10. Trivedi HN, Plummer FA, Anzala AO, Njagi E, Bwayo JJ, Ngugi EN, et al. Resistance to HIV-1 infection among African sex workers is associated with global hyporesponsiveness in interleukin 4 production. Faseb J 2001; 15:1795-1797.
11. Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, et al. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses 1998; 14:1521-1530.
12. Dunand VA, Ng CM, Wade JA, Bwayo J, Plummer FA, MacDonald KS. HLA-DR 52- and 51-associated DRB1 alleles in Kenya, east Africa. Tissue Antigens 1997; 49:397-402.
13. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Ball TB, et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000; 181:1581-1589.
14. MacDonald KS, Matukas L, Embree JE, Fowke KR, Kimani J, Nagelkerke NJ, et al. Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 2001; 79:151-157.
15. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1:3-19.
16. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2001; 2:61-70.
17. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G, Kimberly R, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002; 3:313-330.
18. Hughes AE. Optimization of microsatellite analysis for genetic mapping. Genomics 1993; 15:433-434.
19. Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP. Activities of IRF-1. J Interferon Cytokine Res 2002; 22:5-14.
20. Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant MJ, LePage C, et al. Interferon regulatory factors: the next generation. Gene 1999; 237:1-14.
21. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, et al. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 2002; 195:1359-1370.
22. Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res 2002; 22:27-37.
23. Ji H, Ball TB, Kimani J, Plummer FA. Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. J Hum Genet 2004; 49:528-535.
24. Moore MJ. Gene expression. When the junk isn't junk. Nature 1996; 379:402-403.
25. Herbert A. RNA editing, introns and evolution. Trends Genet 1996; 12:6-9.
26. Mattick JS. Introns: evolution and function. Curr Opin Genet Dev 1994; 4:823-831.
27. Lloyd C, Gunning P. Noncoding regions of the gamma-actin gene influence the impact of the gene on myoblast morphology. J Cell Biol 1993; 121:73-82.
28. Frederickson RM, Micheau MR, Iwamoto A, Miyamoto NG. 5′ flanking and first intron sequences of the human beta-actin gene required for efficient promoter activity. Nucl Acids Res 1989; 17:253-270.
29. Dirksen WP, Sun Q, Rottman FM. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J Biol Chem 1995; 270:5346-5352.
30. Chabot B. Directing alternative splicing: cast and scenarios. Trends Genet 1996; 12:472-478.
31. Marsili G, Borsetti A, Sgarbanti M, Remoli AL, Ridolfi B, Stellacci E, et al. On the role of interferon regulatory factors in HIV-1 replication. Ann N Y Acad Sci 2003; 1010:29-42.
32. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, Lu D, et al. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 1997; 71:1911-1921.
33. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783-792.
34. Nakayama EE, Hoshino Y, Xin X, Liu H, Goto M, Watanabe N, et al. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol 2000; 74:5452-5459.
35. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, et al. Protective effect of interleukin-4-589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis 2002; 185:1183-1186.